Global Vectra Helicorp Intrinsic Value
Global Vectra Helicorp (GLOBALVECT) median intrinsic value is ₹297.71 from 3 valuation models (range ₹90–₹372), vs current price ₹148.95 — +99.9% upside (Trading Below Calculated Value), margin of safety 50.0%. Analyse GLOBALVECT shareholder distribution to track promoter, FII and institutional holdings.
GLOBALVECT Valuation Methods Summary — DCF, Graham Number & P/E
Global Vectra Helicorp intrinsic value across 3 models vs current price ₹148.95 — upside/downside and value range per method. For current market price and key ratios, visit GLOBALVECT screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Revenue Multiple Method | revenue | ₹297.71 | ₹267.94 - ₹327.48 | +99.9% | Revenue/Share: ₹372.14, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹90.00 | ₹81.00 - ₹99.00 | -39.6% | EBITDA: ₹21.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹372.38 | ₹297.90 - ₹446.86 | +150.0% | CF Growth: 15.0%, Discount: 15% |
GLOBALVECT Intrinsic Value vs Market Price — All Valuation Models
Global Vectra Helicorp fair value range ₹90–₹372 vs current market price ₹148.95 across 3 valuation models. Read GLOBALVECT dividend payout details for the complete payout history and dividend yield track record.
GLOBALVECT Intrinsic Value Analysis — Undervalued or Overvalued?
Global Vectra Helicorp median intrinsic value ₹297.71, current price ₹148.95 — Trading Below Calculated Value by 99.9%, margin of safety 50.0%.
What is the intrinsic value of GLOBALVECT?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Global Vectra Helicorp (GLOBALVECT) is ₹297.71 (median value). With the current market price of ₹148.95, this represents a +99.9% variance from our estimated fair value.
The valuation range spans from ₹90.00 to ₹372.38, indicating ₹90.00 - ₹372.38.
Is GLOBALVECT undervalued or overvalued?
Based on our multi-method analysis, Global Vectra Helicorp (GLOBALVECT) appears to be trading below calculated value by approximately 99.9%.
GLOBALVECT Financial Health — Key Ratios vs Industry Benchmarks
Global Vectra Helicorp financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.58 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 587.5% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.59x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
GLOBALVECT Cash Flow Quality — Operating & Free Cash Flow
Global Vectra Helicorp operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹98 Cr | ₹98 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹111 Cr | ₹111 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹29 Cr | ₹29 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹60 Cr | ₹60 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹10 Cr | ₹10 Cr | Positive Free Cash Flow | 8/10 |